# Source Natural (NSE: SOURCENTRL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SOURCENTRL · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹70 Cr, it ranks 2877th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Packaged Foods.

Its return on equity was 14.2% in FY26. Promoters held 74.37% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹70 Cr |
| ROE | 14.2% (FY26) |
| ROCE | 21.1% (FY26) |
| Debt to equity | 0.3 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹45 Cr | ₹3 Cr |
| FY24 | ₹27 Cr | ₹2 Cr |
| FY23 | ₹20 Cr | ₹2 Cr |
| FY22 | ₹22 Cr | ₹2 Cr |
| FY21 | ₹25 Cr | ₹3 Cr |
| FY20 | ₹14 Cr | ₹2 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 74.37%
- Non-institutions: 25.63%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Maestros Elect](https://app.pivotnow.in/stock/METSL) | — | ₹76 Cr | — | — |
| [Bharat Immuno](https://app.pivotnow.in/stock/BIBCL) | — | ₹75 Cr | — | — |
| [Asston Pharma](https://app.pivotnow.in/stock/APL) | — | ₹69 Cr | — | — |
| [Fervent Synergi](https://app.pivotnow.in/stock/FERVENTSYN) | — | ₹68 Cr | — | — |
| [Sunil Health](https://app.pivotnow.in/stock/SUNLOC) | ₹65.00 | ₹67 Cr | 16.6 | — |
| [Samrat Pharma](https://app.pivotnow.in/stock/SAMRATPH) | — | ₹61 Cr | — | — |

## Questions and answers

### What is the market cap of Source Natural?

Source Natural's market capitalisation is ₹70 Cr (₹70 Cr) at the 22 Oct 2026 close, ranking 2877th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Source Natural?

Return on equity was 14.2% in FY26 and return on capital employed was 21.1% in FY26 (standalone figures).

### Is Source Natural a debt-free company?

No. Source Natural's debt-to-equity ratio was 0.3 in FY26, with total debt of ₹0 Cr.

### What is the shareholding pattern of Source Natural?

As of 30 Jun 2026: promoters 74.37%, non-institutions 25.63%.

### Who are Source Natural's competitors?

The listed Pharma & Healthcare companies closest to Source Natural by market cap are Maestros Elect, Bharat Immuno, Asston Pharma, Fervent Synergi, Sunil Health and Samrat Pharma.

### Is Source Natural a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Source Natural's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SOURCENTRL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.